Send mail to Author

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____       ___     __   __     ___     _    _    __   __  
|  __ \\    / _ \\   \ \\/ //   / _ \\  | |  | ||  \ \\/ // 
| |  \ ||  / //\ \\   \   //   / //\ \\ | |/\| ||   \ ` //  
| |__/ || |  ___  ||  / . \\  |  ___  |||  /\  ||    | ||   
|_____//  |_||  |_|| /_//\_\\ |_||  |_|||_// \_||    |_||   
 -----`   `-`   `-`  `-`  --` `-`   `-` `-`   `-`    `-`'
 


Back to frontdoor view

OPUS4 Logo